1 |
Villar M, Urra JM, Rodríguez-Del-Río FJ, Artigas-Jerónimo S, Jiménez-Collados N, Ferreras-Colino E, Contreras M, de Mera IGF, Estrada-Peña A, Gortázar C, de la Fuente J. Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology. Front Immunol 2021;12:730710. [PMID: 34566994 DOI: 10.3389/fimmu.2021.730710] [Reference Citation Analysis]
|
2 |
Campos-Ferreira D, Visani V, Córdula C, Nascimento GA, Montenegro LML, Schindler HC, Cavalcanti IMF. COVID-19 challenges: From SARS-CoV-2 infection to effective point-of-care diagnosis by electrochemical biosensing platforms. Biochem Eng J 2021;176:108200. [PMID: 34522158 DOI: 10.1016/j.bej.2021.108200] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Rouka E, Gourgoulianis KI, Zarogiannis SG. In silico investigation of the viroporin E as a vaccine target against SARS-CoV-2. Am J Physiol Lung Cell Mol Physiol 2021;320:L1057-63. [PMID: 33822639 DOI: 10.1152/ajplung.00443.2020] [Reference Citation Analysis]
|
4 |
Hu S, Jiang S, Qi X, Bai R, Ye XY, Xie T. Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review. Drug Dev Res 2021. [PMID: 34762760 DOI: 10.1002/ddr.21895] [Reference Citation Analysis]
|
5 |
Rashidi S, Tuteja R, Mansouri R, Ali-Hassanzadeh M, Shafiei R, Ghani E, Karimazar M, Nguewa P, Manzano-Román R. The main post-translational modifications and related regulatory pathways in the malaria parasite Plasmodium falciparum: An update. J Proteomics 2021;245:104279. [PMID: 34089893 DOI: 10.1016/j.jprot.2021.104279] [Reference Citation Analysis]
|
6 |
Yu W, Bai Y, Raha A, Su Z, Geng F. Integrative In Silico Investigation Reveals the Host-Virus Interactions in Repurposed Drugs Against SARS-CoV-2. Front Bioinform 2022;1:763540. [DOI: 10.3389/fbinf.2021.763540] [Reference Citation Analysis]
|